Personalized synthetic lethality induced by targeting RAD52 in leukemias identified by gene mutation and expression profile

Authors:

Abstract
Key Points: Targeting RAD52 DNA binding domain I by peptide aptamer induces synthetic lethality in BRCA-deficient leukemias. Individual patients with BRCA-deficient leukemias could be identified by genetic and epigenetic profiling.